Skip to main content
. Author manuscript; available in PMC: 2016 Jun 27.
Published in final edited form as: J Gen Virol. 2013 Apr 11;94(Pt 7):1535–1546. doi: 10.1099/vir.0.051201-0

Fig. 5.

Fig. 5

Investigation of reversion in three HRV1A mutants bearing VP1/2Apro cleavage site mutations. A 50% confluent monolayer of HeLa cells was transfected using DEAE dextran at 34°C with 1.2 μg of in vitro transcribed HRV1A wt or the indicated mutant RNA. H2O was used instead of RNA for negative controls. 25 minutes post transfection, cells were washed with PBS and covered with 1% low melting agarose in infection medium. Plaques were visualized with crystal violet 48h or 72h post transfection to visualize viral plaques.